Revenue: The sum of all revenue fields included for a company's operating activities.
ADC Therapeutics SA (ADCT) had Revenue of $23.03M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$23.03M |
$-38.60M |
|
$2.06M |
|
$20.97M |
|
$51.50M |
|
$-28.46M |
|
$-9.97M |
|
$-38.44M |
|
$-38.44M |
|
$-38.60M |
|
$-38.60M |
|
$-38.60M |
|
$-38.60M |
|
$-28.46M |
|
$-27.66M |
|
107.20M |
|
107.20M |
|
$-0.36 |
|
$-0.36 |
|
| Balance Sheet Financials | |
$257.99M |
|
$5.16M |
|
$14.55M |
|
$272.54M |
|
$57.79M |
|
$113.82M |
|
$452.97M |
|
$510.76M |
|
$-238.22M |
|
$-238.22M |
|
$-238.22M |
|
99.18M |
|
| Cash Flow Statement Financials | |
$-56.33M |
|
$-0.26M |
|
$0.27M |
|
$250.87M |
|
$194.70M |
|
$-56.17M |
|
$2.42M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.46 |
|
-- |
|
-- |
|
-0.92 |
|
-0.48 |
|
91.05% |
|
-123.58% |
|
-123.58% |
|
-- |
|
-166.88% |
|
-167.59% |
|
$-56.60M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.12 |
|
0.73 |
|
124.11 |
|
16.20% |
|
16.20% |
|
-14.16% |
|
31.03% |
|
$-2.40 |
|
$-0.53 |
|
$-0.53 |
|